Degradation of cell proteins and the generation of MHC class I-presented peptides

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 739-779

  Rock, Kenneth L ^a   Goldberg, Alfred L ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antigen presentation; Antigen processing; Antigenic peptide; Cytotoxic T lymphocyte; Proteasome; Protein degradation; Proteolysis; Ubiquitin

Indexed keywords

AMINO ACID; AMINOPEPTIDASE; CELL PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN; OLIGOPEPTIDE; PEPTIDE; PROTEASOME; PROTEINASE; UBIQUITIN;

AMINO ACID SYNTHESIS; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CELL SURFACE; CYTOTOXIC T LYMPHOCYTE; ENDOPLASMIC RETICULUM; INTRACELLULAR TRANSPORT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; CELL MEMBRANE; CYSTEINE ENDOPEPTIDASES; CYTOPLASM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MULTIENZYME COMPLEXES; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; UBIQUITINS;

EID: 0032971227     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.739     Document Type: Review

References (221)

1. York I, Rock KL. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369-96
2. Williams D, Watts T. 1995. Molecular chaperones in antigen presentation. Curr. Opin. Immunol. 7:77-84
3. Hughes EA, Cresswell P. 1998. The thiol oxidoreductase ERp57 is a component of the MHC class I peptide-loading complex. Curr. Biol. 8:709-12
4. Lindquist JA, Jensen ON, Mann M, Hammerling GJ. 1998. ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly. EMBO J. 17:2186-95
5. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, Grandea AG, Riddell SR, Tampe R, Spies T, Trowsdale J, Cresswell P. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science 277:1306-9
6. Madden DR. 1995. The three-dimensional structure of peptide-MHC complexes. Annu. Rev. Immunol. 13:587-622
7. Braciale TJ, Morrison LA, Sweetser MT, Sambrook J, Gething M-J, Braciale VL. 1987. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes. Immunol. Rev. 98:95-114
8. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL. 1994. Inhibitors of the proteasome block nonlysosomal protein degradation and the generation of peptides presented on MHC-class I molecules. Cell 78:761-71
9. Germain RN, Margulies DH. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-50
10. Bennink JR, Yewdell JW, Gerhard W. 1982. A viral polymerase involved in recognition of influenza virus-infected cells by a cytotoxic T-cell clone. Nature 296:75-76
11. Gooding LR, O'Connell KA. 1983. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J. Immunol. 131:2580-86
12. Townsend ARM, Bastin J, Gould K, Brownlee GG. 1986. Cytotoxic T lymphocytes recognize influenza hemagglutinin that lacks a signal sequence. Nature 324:575-77
13. Moore MW, Carbone FR, Bevan MJ. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777-85
14. Yewdell JW, Bennick JR, Hosaka Y. 1988. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science 239:637-40
15. Townsend A, Öhlen C, Bastin J, Ljunggren H-G, Foster L, Kärre K. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443-48
16. Momburg F, Hammerling GJ. 1998. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv. Immunol. 68:191-256
17. Henderson RA, Michel H, Sakaguchi K, Shabanowitz J, Appella E, Hunt DF, Engelhard VH. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255:1264-66
18. Kurepa Z, Hasemann C, Forman J. 1998. Qa 1b binds conserved class I leader peptides derived from several mammalian species. Submitted for publication
19. Zweerink HJ, Gammon MC, Utz U, Sauma SY, Harrer T, Hawkins JC, Johnson RP, Sirotina A, Hermes JD, Walker BD, et al. 1993. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 150:1763-71
20. + CTL. J. Immunol. 154:6140-56
21. Snyder HL, Bacik I, Bennink JR, Kearns G, Behrens TW, Bachi T, Orlowski M, Yewdell JW. 1997. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class I antigen processing. J. Exp. Med. 186:1087-98
22. Ward CL, Omura S, Kopito RR. 1995. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121-27
23. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR. 1999. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83:129-35
24. Huppa JB, Ploegh HL. 1997. The alpha chain of the T cell antigen receptor is degraded in the cytosol. Immunity 7:113-22
25. Hughes EA, Hammond C, Cresswell P. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA 94:1896-901
26. Sommer T, Wolf DH. 1997. Endoplasmic reticulum degradation: reverse protein flow of no return. FASEB J. 11:1227-33
27. Hilt W, Wolf D. 1996. Proteasomes: destruction as a programme. Trends Biochem. Sci. 21:96-102
28. Mosse C, Meadows L, Luckey C, Kittlesen D, Huczko E, Slingluff C, Shabanowitz J, Hunt D, Engelhard V. 1998. The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187:37-48
29. Van Pel A, Boon T. 1989. T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis. Immunogenetics 29:75-79
30. Shastri N, Nguyen V, Gonzalez F. 1995. Major histocompatibility class I molecules can present cryptic translation products to T-cells. J. Biol. Chem. 270:1088-91
31. Yewdell J, Anton L, Bennink J. 1996. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J. Immunol. 157:1823-26
32. Bullock T, Eisenlohr L. 1996. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J. Exp. Med. 184:1319-29
33. Loveland B, Wang CR, Yonekawa H, Hermel E, Lindahl KF. 1990. Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein. Cell 60:971-80
34. Desautels M, Goldberg AL. 1982. Demonstration of an ATP-dependent, vanadate-sensitive endoprotease in the matrix of rat liver mitochondria. J. Biol, Chem. 257:11673-79
35. Kuzela S, Goldberg AL. 1994. The mitochondrial ATP-dependent protease from rat liver and yeast. Methods Enzymol., pp. 376-83
36. Langer T, Neupert W. 1996. Regulated protein degradation in mitochondria. Experientia 52:1065-76
37. Goldberg AL. 1992. The mechanism and functions of ATP-dependent proteases in bacterial and animal cells. Eur. J. Biochem. 203:9-23
38. Gottesman S, Maurizi M. 1992. Regulation by proteolysis: energy-dependent proteases and their targets. Microbiol. Rev. 56:592-621
39. Lindahl KF, Byers DE, Dabhi VM, Hovik R, Jones EP, Smith GP, Wang CR, Xiao H, Yoshino M. 1997. H2-M3, a full-service class 1b histocompatibility antigen. Annu. Rev. Immunol. 15:851-79
40. Goldberg A, St. John A. 1976. Intracellular protein degradation in mammalian and bacterial cells. Annu. Rev. Biochem. 45:747-803
41. Rechsteiner M. 1987. Ubiquitin-mediated pathways for intracellular proteolysis. Annu. Rev. Cell Biol. 3:1-30
42. Hershko A, Ciechanover A. 1992. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61:761-807
43. Murray A, Kirschner M. 1989. Dominoes and clocks: the union of two views of the cell cycle. Science 246:614-21
44. Palombella V, Rando O, Goldberg A, Maniatis T. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773 85
45. Orian A, Whiteside S, Israel A, Stancovski I, Schwartz AL, Ciechanover A. 1995. Ubiquitin-mediated processing of NF-κB transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J. Biol, Chem. 270:21707-14
46. Dice J. 1987. Molecular determinants of protein half-lives in eukaryotic cells, FASEB J. 1:349-57
47. Morrison LA, Lukacher A, Braciale VL, Fan DP, Braciale TJ. 1986. Differences in antigen presentation to MHC class I and class II-restricted influenza virus-specific cytolytic T lympyhocyte clones. J. Exp. Med. 163:903-21
48. Gronostajski R, Pardee A, Goldberg A. 1985. The ATP dependence of the degradation of short-and long-lived proteins in growing fibroblasts. J. Biol. Chem. 260:3344-49
49. Etlinger J, Goldberg A. 1977. A soluble ATP-dependent protcolytic system responsible for the degradation of abnormal proteins in reticulocytes. Proc. Natl. Acad. Sci. USA 74:54-58
50. Hershko A, Ciechanover A. 1992. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61:761-807
51. Hershko A. 1988. Ubiquitin-mediated protein degradation. J. Biol. Chem. 263: 15237-40
52. Finley D, Chau V. 1991. Ubiquitination. Annu. Rev. Cell Biol. 7:25-69
53. Ciechanover A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79:13-21
54. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-79
55. Hershko A, Ganoth D, Sudakin V, Dahan A, Cohen LH, Luca FC, Ruderman JV, Eytan E. 1994. Components of a system that ligates cyclin to ubiquitin and their regulation by the protein kinase cdc2. J. Biol. Chem. 269:4940-46
56. Coux O, Tanaka K, Goldberg A. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem, 65:801-4
57. Ciechanover A, Finley D, Varshavsky A. 1984. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell 37:57-66
58. Murakami Y, Matsufuji S, Kameji T, Hayashi S, Igarashi K, Tamura T, Tanaka K, Ichihara A. 1992. Ornithinc decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360:597-99
59. Driscoll J, Goldberg A. 1990. The proteasome (multicatalytic protease) is a component of the 1500-kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J. Biol. Chem. 265:4789-92
60. Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-80
61. Zwickl P, Woo K, Ng D, Klenk H-P, Goldberg A. 1998. A novel 650 kDATPase complex, related to the eukaryotic 26S ATPases, activates protein breakdown by 20S proteasomes from Arhaea. Submitted for publication
62. Townsend A, Bastin J, Gould K, Brownlee G, Andrew M, Coupar B, Boyle D, Chan S, Smith G. 1988. Defective presentation to class I-restricted by cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J. Exp. Med. 168:1211-24
63. Michalek M, Grant E, Gramm C, Goldberg A, Rock K. 1993. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 363:552-54
64. Grant E, Michalek M, Goldberg A, Rock K. 1995. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J. Immunol. 155:3750-58
65. Michalek M, Grant E, Rock K. 1996. Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation. J. Immunol. 157:617-24
66. Ben-Shahar S, Cassouto B, Novak L, Porgador A, Reiss Y. 1997. Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate. J. Biol. Chem. 272:21060-66
67. Varshavsky A. 1992. The N-end rule. Cell 69:725-35
68. Tobery T, Siliciano R. 1997. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J. Exp. Med. 185:909-20
69. Wu Y, Kipps T. 1997. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome-dependent degradation are highly efficient inducers of cytolytic T lymphocytes. J. Immunol. 159:6037-43
70. Rodriguez F, Zhang J, Whitton J. 1997. DNA immunization: Ubiquitination of a viral protein enhances cytotoxic T-lymphocyte induction and antiviral protection but abrogates antibody induction. J. Virol. 71:8497-503
71. Goth S, Nguyen V, Shastri N. 1996. Generation of naturally processed peptide/MHC class I complexes is independent of the stability of endogenously synthesized precursors. J. Immunol. 157: 1894-904
72. Kisselev A, Akopian T, Castillo V, Goldberg A. 1998. Certain proteoytic sites in mammalian 20S proteasomes allosterically regulate activities of other sites, suggesting an ordered mechanism for protein breakdown. Submitted for publication
73. Yellen-Shaw AJ, Wherry EJ, Dubois GC, Eisenlohr LC. 1997. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158:3227-34
74. Cox JH, Galardy P, Bennink JR, Yewdell JW. 1995. Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines. J. Immunol. 154: 511-19
75. Finley D, Ciechanover A, Varshavsky A. 1984. Thermolability of ubiquitin-activating enzyme from the mammalian cell cycle mutant ts85. Cell 37:43-55
76. Goldberg A, Rock K. 1992. Proteolysis, proteosomes and antigen presentation. Nature 357:375-79
77. Rechsteiner M, Hoffman L, Dubiel W. 1993. The multicatalytic and 26S proteases. J. Biol. Chem. 268:6065-68
78. Rivett A. 1993. Proteasomes: multicatalytic proteinase complexes. Biochem. J. 291:1-10
79. Coux O, Tanaka K, Goldberg ALI. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-47
80. Deleted in proof
81. Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R. 1995. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 Å resolution [see comments]. Science 268:533-39
82. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R. 1997. Structure of 20S proteasome from yeast at 2.4 Å resolution [see comments]. Nature 386:463-71
83. Seemuller E, Lupas A, Stock D, Lowe J, Huber R, Baumeister W. 1995. Proteasome from Thermoplasma acidophilum: a threonine protease. Science 268:579-82
84. Arendt CS, Hochstrasser M. 1997. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation. Proc. Natl Acad. Sci. USA 94:7156-61
85. Seemuller E, Lupas A, Zuhl F, Zwickl P, Baumeister W. 1995. The proteasome from Thermoplasma acidophilum is neither a cysteine nor a serine protease. FEBS Lett. 359:173-78
86. Fenteany S, Standaert RF, Lane WJ, Choi S, Corey EJ, Schreiber SL. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726-31
87. Bogyo M, McMaster J, Gaczynska M, Tortorella D, Goldberg A, Ploegh H. 1997. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HsIV by a new class of inhibitors. Proc. Natl Acad. Sci. USA 4:6629-34
88. Akopian TN, Kisselev AF, Goldberg AL. 1997. Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J. Biol. Chem. 272:1791-98
89. Zwickl P, Kleinz J, Baumeister W. 1994. Critical elements in proteasome assembly. Nat. Struct. Biol. 1:765-70
90. Schmidtke G, Kraft R, Kostka S, Henklein P, Frommel C, Lowe J, Huber R, Kloetzel PM, Schmidt M. 1996. Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-sub units is an ordered two-step mechanism involving autocatalysis. EMBO J. 15:6887-98
91. Schmidtke G, Schmidt M, Kloetzel PM. 1997. Maturation of mammalian 20S proteasome: purification and characterization of 13S and 16S proteasome precursor complexes. J. Mol. Biol. 268:95-106
92. Nandi D, Woodward E, Ginsburg DB, Monaco JJ. 1997. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits. EMBO J. 16:5363-75
93. Beninga J, Goldberg A. 1998. Function of the proteasome in antigen presentation. In Uniquitin and the Biology of the Cell, ed. J Peters, J Harris, D Finley, pp. 191-221. New York: Plenum
94. Orlowski M. 1990. The multicatalytic proteinase complex, a major extralysosomal proteolytic complex. Biochemistry 29:10289-97
95. Heinemeyer W, Gruhler A, Mohrle V, Mahe Y, Wolf DH. 1993. PRE2, highly homologous to the human major histocompatibility complex-linked RING 10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins. J. Biol. Chem. 268:5115-20
96. Enenkel C, Lehmann H, Kipper J, Guckel R, Hilt W, Wolf DH. 1994. PRE3, highly homologous to the human major histocompatibility complex-linked LMP2 (RING 12) gene, codes for a yeast proteasome subunit necessary for the peptidylglutamyl-peptide hydrolyzing activity. FEBS Lett. 341:193-96
97. Gaczynska M, Rock KL, Spies T, Goldberg A. 1994. Peptidase activities of proteasomes are differentially regulated by the MHC-encoded genes LMP2 and LMP7. Proc. Natl. Acad. Sci USA 91: 9212-17
98. Gaczynska M, Goldberg A, Tanaka K, Hendil K, Rock K. 1996. Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-gamma-induced subunits LMP2 and LMP7. J. Biol. Chem. 271:17275-80
99. Kisselev AF, Akopian TN, Goldberg AL. 1998. Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes. J. Biol. Chem. 273:1982-89
100. Orlowski M, Cardozo C, Michaud C. 1993. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Biochemistry 32:1563-72
101. McCormack T, Cruikshank A, Grenier L, Melandri F, Nunes S, Plamondon L, Stein R, Dick L. 1998. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin betalactone. Biochemistry 37:7792-800
102. Rohrwild M, Pfeifer G, Santarius U, Muller SA, Huang HC, Engel A, Baumeister W, Goldberg AL. 1997. The ATP-dependent HslVU protease from Escherichia coli is a four-ring structure resembling the proteasome. Nat. Struct. Biol. 4:133-39
103. Glickman MH, Rubin DM, Fried VA, Finley D. 1998. The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol. Cell. Biol. 18:3149-62
104. DeMartino GN, Moomaw CR, Zagnitko OP, Proske RJ, Chu-Ping M, Afendis SJ, Swaffield JC, Slaughter CA. 1994. PA700, an ATP-dependent activator of the 20S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family. J. Biol. Chem. 269:20878-84
105. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, Finley D. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94:615-23
106. Pickart CM. 1997. Targeting of substrates to the 26S proteasome. FASEB J. 11:1055-66
107. Chu-Ping M, Slaughter CA, DeMartino GN. 1992. Purification and characterization of a protein inhibitor of the 20S proteasome (macropain). Biochim. Biophys. Acta 1119:303-11
108. Dubiel W, Pratt G, Ferrell K, Rechsteiner M. 1992. Purification of an 11S regulator of the multicatalytic protease. J. Biol. Chem. 267:22369-77
109. Ma CP, Slaughter CA, DeMartino GN. 1992. Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J. Biol. Chem. 267:10515-23
110. Gray CW, Slaughter CA, DeMartino GN. 1994. PA28 activator protein forms regulatory caps on proteasome stacked rings. J. Mol. Biol. 236:7-15
111. Knowlton JR, Johnston SC, Whitby FG, Realini C, Zhang Z, Rechsteiner M, Hill CP. 1997. Structure of the proteasome activator REGalpha (PA28alpha). Nature 390:639-43
112. Song X, Mott JD, von Kampen J, Pramanik B, Tanaka K, Slaughter CA, DeMartino GN. 1996. A model for the quaternary structure of the proteasome activator PA28. J. Biol. Chem. 271:26410-17
113. Kuehn L, Dahlmann B. 1996. Reconstitution of proteasome activator PA28 from isolated subunits: optimal activity is associated with an alpha,beta-heteromultimer. FEBS Lett. 394:183-86
114. Realini C, Dubiel W, Pratt G, Ferrell K, Rechsteiner M. 1994. Molecular cloning and expression of a gamma-interferon-inducible activator of the multicatalytic protease. J. Biol. Chem. 269:20727-32
115. Ahn JY, Tanahashi N, Akiyama K, Hisamatsu H, Noda C, Tanaka K, Chung CH, Shibmara N, Willy PJ, Mott JD, el al. 1995. Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome. FEBS Lett. 366:37-42
116. Tanahashi N, Yokota K-y, Ahn JY, Chung CH, Fujiwara T, Takahashi E-I, DeMartino GN, Slaughter CA, Toyonaga T, Yamamura K-I, Shimbara N, Tanaka K. 1997. Genes Cells 2:195-211
117. Realini C, Jensen C, Zhang Z-G, Jhonston S, Knowlton J, Hill C, Rechsteiner M. 1997. Characterization of recombinant REGalpha, REGbeta and REGgamma proteasome activators. J. Biol. Chem. 272:25483 92
118. Kania MA, Demartino GN, Baumeister W, Goldberg AL. 1996. The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator. Eur. J. Biochem. 236:510-16
119. Groettrup M, Soza A, Eggers M, Kuehn L, Dick TP, Schild H, Rammensee HG, Koszinowski UH, Kloetzel PM. 1996. A role for the proteasome regulator PA28 alpha in antigen presentation. Nature 381:166-68
120. Hendil KB, Khan S, Tanaka K. 1998. Simultaneous binding of PA28 and PA700 activators to 20S proteasomes. Biochem. J. 332:749-54
121. Harding C, France J, Song R, Farah J, Chatterjee S, Iqbal M, Siman R. 1995. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J. Immunol. 155:1767-75
122. Lee DH, Goldberg A. 1998. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8:397-403
123. Lee DH, Goldberg A. 1996. Selective inhibitors of the proteasome and vacuola, pathways in Saccharomyces cerevisiae. J. Biol. Chem. 271:287280-84
124. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL. 1996. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone. J. Biol. Chem. 271:7273-76
125. Craiu A, Gaczynska M, Akopian T, Gramm C, Fenteany G, Goldberg A, Rock KL. 1997. Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272:13437-45
126. Bush KT, Goldberg AL, Nigam SK. 1997. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J. Biol. Chem. 272:9086-92
127. Mathur M, Morimoto R. 1998. Heat shock response and protein degradation: regulation of HSF2 by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 18:5091-8
128. Meriin AB, Gabai VL, Yaglom J, Shifrin VI, Sherman MY. 1998. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis. J. Biol. Chem. 273:6373-79
129. Dick LR, Aldrich C, Jameson SC, Moomaw CR, Pramanik BC, Doyle CK, DeMartino GN, Bevan MJ, Forman JM, Slaughter CA. 1994. Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J. Immunol. 152:3884-94
130. Boes B, Hengel H, Ruppert T, Multhaup G, Koszinowski U, Kloetzel P. 1993. Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179:901-9
131. Niedermann G, Butz S, Thlenfeldt H, Grimm R, Lucchiari M, Hoschutzky H, Jung G, Maier B, Eichmann K. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289-99
132. Cerundolo V, Benham A, Braud V, Mukherjee S, Gould K, Macino B, Neefjes J. Townsend A. 1997. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27:336-41
133. Benham AM, Neejes JJ. 1997. Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation. J. Immunol. 159:5896-904
134. 126b, Benham A, Gromme M, Neefjes J. 1998. Allelic differences in the relationship between proteasome activity and MHC class I peptide loading. J. Immunol. 161:83-89
135. Monaco JJ, McDevitt HO. 1984. H-2-linked low-molecular weight polypeptide antigens assemble into an unusual macromolecular complex. Nature 309:797-99
136. Monaco J, McDevitt H. 1986. The LMP antigens: a stable MHC-controlled multisubunit protein complex. Hum. Immunol. 15:416-26
137. Parham P. 1990. Antigen processing. Transporters of delight [news; comment]. Nature 348:674-75
138. Brown MG, Driscoll J, Monaco JJ. 1991. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes [see comments]. Nature 353:355-57
139. Ortiz-Navarrete V, Seelig A, Gernold M, Frentzel S, Kloetzel P, Hammerling G. 1991. Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex. Nature 353:662-64
140. Martinez CK, Monaco JJ. 1991. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 353:664-67
141. Glynne R, Powis S, Beck S, Kelly A, Kerr L, Trowsdale J. 1991. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:357-60
142. Kelly A, Powis SH, Glynne R, Radley E, Beek S, Trowsdale J. 1991. Second proteasome-related gene in the human MHC class II region. Nature 353:667-68
143. Tanaka K. 1998. Molecular biology of the proteasome. Biochem. Biophys. Res. Commun. 247:537-41
144. Hisamatsu H, Shimbara N, Saito Y, Kristensen P, Hendil KB, Fujiwara T, Takahashi E, Tanahashi N, Tamura T, Ichihara A, Tanaka K. 1996. Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. J. Exp. Med. 183:1807-16
145. Yang Y, Waters JB, Fruh K, Peterson PA. 1992. Proteasomes are regulated by interferon gamma: implications for antigen processing. Proc. Natl. Acad. Sci. USA 89:4928-32
146. Aki M, Shimbara N, Takashina M, Akiyama K, Kagawa S, Tamura T, Tanahashi N, Yoshimura T, Tanaka K, Ichihara A. 1994. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J. Biochem. 115(2):257-69
147. Akiyama K, Yokota K, Kagawa S, Shimbara N, Tamura T, Akioka H, Nothwang HG, Noda C, Tanaka K, Ichihara A. 1994. cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y. Science 265:1231-34
148. Fruh K, Gossen M, Wang K, Bujard H, Peterson PA, Yang Y. 1994. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J. 13:3236-44
149. Griffin TA, Nandi D, Cruz M, Fehling HJ, Kaer LV, Monoco JJ, Colbert RA. 1998. Immunoproteasome assembly: cooperative incorporation of interferon gamma (1FN-gamma)-inducible subunits. J. Exp. Med. 187:97-104
150. Arnold D, Driscoll J, Androlewicz M, Hughes E, Cresswell P, Spies T. 1992. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules. Nature 360:171-74
151. Momburg F, Ortiz-Navarrete V, Neefjes J, Goulmy E, van de Wa Y, Spits H, Powis S, Butcher G, Howard J, Walden P, et al. 1992. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation. Nature 360:174-77
152. Yewdell J, Lapham C, Bacik I, Spies T, Bennink J. 1994. MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation. J. Immunol. 152:1163-70
153. Fehling H, Swat W, Laplace C, Kuhn R, Rajewsky K, Muller U, von Bochmer H. 1994. MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265:1234-37
154. + T cells. Cell 71:1205-14
155. + proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes. Curr. Biol. 5:923-30
156. Cerundolo V, Kelly A, Elliott T, Trowsdale J, Townsend A. 1995. Genes encoded in the major histocompatibility complex affecting the generation of peptides for TAP transport. Eur. J. Immanol. 25:554-62
157. Gaczynska M, Rock K, Goldberg A. 1993. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264-67
158. Driscoll J, Brown M, Finley D, Monaco J. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365:262-64
159. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S. 1994. Altered peptidase and antiviral activities in LMP2 mutant mice. Immunity 1:533-41
160. Hilt W, Enenkel C, Gruhler A, Singer T, Wolf DH. 1993. The PRE4 gene codes for a subunit of the yeast proteasome necessary for peptidylglutamyl-peptide-hydrolyzing activity. Mutations link the proteasome to stress-and ubiquitin-dependent proteolysis. J. Biol. Chem. 268:3479-86
161. Ustrell V, Realini C, Pratt G, Rechsteiner M. 1995. Human lymphoblast and erythrocyte multicatalytic proteases: differential peptidase activities and responses to the 11S regulator. FEBS Lett. 376:155-58
162. Ustrell V, Pratt G, Rechsteiner M. 1995. Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases. Proc. Natl. Acad. Sci. USA 92:584-88
163. Kuckelkorn U, Frentzel S, Kraft R, Kostka S, Groettrup M, Kloetzel PM. 1995. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma. Eur. J. Immunol. 25:2605-11
164. Stohwasser R, Kuckelkorn U, Kraft R, Kostka S, Kloetzel PM. 1996. 20S proteasome from LMP7 knock out mice reveals altered proteolytic activities and cleavage site preferences. FEBS Lett. 383:109-13
165. Cardozo C, Kohanski RA. 1998. Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome". J. Biol. Chem. 273:16764-70
166. Rammensee H, Falk K, Rotzschke O. 1993. Peptides naturally presented by MHC class I molecules. Annu. Rev. Immunol. 11:213-44
167. Stern LJ, Wiley DC. 1994. Antigenic peptide binding by class I and class II histocompatibility proteins. Behring Inst. Mitt.: 1-10
168. Stock D, Ditzel L, Baumeister W, Huber R, Lowe J. 1995. Catalytic mechanism of the 20S proteasome of thermoplasma acidophilum revealed by X-ray crystallography. Cold Spring Harbor Symp. Quant. Biol. 60:525-32
169. Wenzel T, Eckerskorn C, Lottspeich F, Baumeister W. 1994. Existence of a molecular ruler in proteasomes suggested by analysis of degradation products. FEBS Lett. 349:205-9
170. Kisselev AF, Akopian TN, Goldberg AL. 1998. Range of sizes of peptide products generated during degradation of different proteins by mammalian 20S and 26S proteasomes. J. Biol. Chem. In press
171. Nussbaum AK, Dick TP, Keilholz W, Schirle M, Stevanovic S, Dietz K, Heinemeyer W, Groll M, Wolf DH, Huber R, Rammensee H-G, Schild H. 1998. Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolast I. Proc. Natl. Acad. Sci. USA 95:12504-9
172. Eggers M, Boes-Fabian B, Ruppert T, Kloetzel PM, Koszinowski UH. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865-70
173. Dick L, Moomaw C, DeMartino G, Slaughter C. 1991. Degradation of oxidized insulin B chain by the multi-proteinase complex macropain (proteasome). Biochemistry 30:2725-34
174. Ehring B, Meyer TH, Eckerskorn C, Lottspeich F, Tampe R. 1996. Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides. Eur. J. Biochem. 235:404-15
175. Bogyo M, Shin S, McMaster JS, Ploegh HL. 1998. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5:307-20
176. Akopian T, Gilbert B, Rando R, Goldberg A. 1998. Potent peptide aldehyde inhibitors of the proteasome indicate an important influence on the P4-P5 positions on peptide binding. Submitted for publication
177. Niedermann G, Grimm R, Geier E, Maurer M, Realini C, Gartmann C, Soll J,
178. Groettrup M, Ruppert T, Kuehn L, Seeger M, Standera S, Koszinowski U, Kloetzel PM. 1995. The interferon-gamma-inducible 11S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20S proteasome in vitro. J. Biol. Chem. 270:23808-15
179. Dick T, Ruppert T, Groettrup M, Kloetzel P, Kuehn L, Koszinowski U, Stevanovic S, Schild H, Rammensee H. 1996. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86:253-62
180. Shimbara N, Nakajima H, Tanahashi N, Ogawa K, Niwa S, Uenaka A, Nakayama E, Tanaka K. 1997. Double-cleavage production of the CTL epitope by proteasomes and PA28: role of the flanking region. Genes Cells 2:785-800
181. Craiu A, Akopian T, Goldberg A, Rock KL. 1997. Two distinct proteolytic processes in the generation of an MHC class I-presented peptide. Prof. Natl. Acad. Sci. USA 94:10850-55
182. Eisenlohr LC, Bacik I, Bennink JR, Bernstein K, Yewdell JW. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes, Cell 71:963-72
183. Snyder H, Yewdell J, Bennink J. 1994. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:2389-94
184. Beninga J, Rock K, Goldberg A. 1998. Interferon-gamma can stimulate post-proteasomal trimming of the N-termini of antigenic peptides by inducing leucine aminopeptidase. J. Biol. Chem. 273:18734-42
185. Androlewicz M, Cresswell P. 1994. Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1:7-14
186. Momburg F, Roelse J, Hammerling G, Neefjes J. 1994. Peptide size selection by the major histocompatibility complex-encoded peptide transporter. J. Exp. Med. 179:1613-23
187. Elliott T, Willis A, Cerundolo V, Townsend A. 1995. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum, J. Exp. Med. 181:1481-91
188. Luckey C, King G, Marto J, Venketeswaran S, Maier B, Crotzer V, Colella T, Shabanowitz J, Hunt D, Engelhard V. 1998. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161:112-21
189. Vinitsky A, Anton L, Snyder H, Orlowski M, Bennink J, Yewdell J. 1997. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors. J. Immunol. 159:554-64
190. Yellen-Shaw A, Eisenlohr L. 1997. Regulation of class I-restricted epitope processing by local or distal flanking sequence. J. Immunol. 158:1727-33
191. Anton LC, Snyder HL, Bennink JR, Vinitsky A, Orlowski M, Porgador A, Yewdell JW. 1998. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides. J. Immunol. 160:4859-68
192. Glas R, Bogyo M, McMaster JS, Gaczynska M, Ploegh HL. 1998. A proteolytic system that compensates for loss of proteasome function. Nature 392:618-22
193. Tamura T, Tamura N, Cejka Z, Hegerl R, Lottspeich F, Baumeister W. 1996. Tricorn protease - the core of a modular proteolytic system [see comments]. Science 274:1385-89
194. Osmulski P, Gaczynska M. 1998. A new large proteolytic complex distinct from the proteasome is present in the cytosol of fission yeast. Curr. Biol. 8:1023-26
195. Pfeifer JD, Wick MJ, Roberts RL, Fidlay K, Normark SJ, Harding CV. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361:359-61
196. Rock KL. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today. In press
197. Kovacsovics-Bankowski M, Rock KL. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules, Science 267:243-46
198. Ossendorp F, Eggers M, Neisig A, Ruppert T, Groettrup M, Sijts A, Mengede E, Kloctzel PM, Neefjes J, Koszinowski U, Melicf C. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation, Immunity 5:115-24
199. Falk K, Rotzschke O, Rammensee HG. 1990. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348:248-51
200. Udono H, Srivastava PK. 1993. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178:1391-96
201. Lammert E, Arnold D, Nijenhuis M, Momburg F, Hammerling GJ, Brunner J, Stevanovic S, Rammensee HG, Schild H. 1997. The endoplasmic reticulum-resident stress protein gp96 binds peptides translocated by TAP. Eur. J. Immunol. 27:923-27
202. Botbol V, Scornik OA. 1979. Intermediates in the degradation of abnormal globin. Bestatin permits the accumulation of the same peptides in cell-free extracts as in intact reticulocytes. J. Biol. Chem. 254:11254-57
203. Beninga J, Akopian T, Rock KL, Goldberg A. 1998. Many MHC class I-presented antigenic peptides are digested in cell extracts by thimet oligopeptidase (EC 3.4.24.15), whose activity is suppressed by interferon-gamma. Submitted for publication
204. Camargo AC, Gomes MD, Reichl AP, Ferro ES, Jacchieri S, Hirata IY, Juliano L. 1997. Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase, Biochem. J. 324:517-22
205. Barrett AJ, Brown MA, Dando PM, Knight CG, McKie N, Rawlings ND, Serizawa A. 1995. Thimet oligopeptidase and oligopeptidase M or neurolysin. Methods Enzymol. 248:529-56
206. Buchler M, Tisljar U, Wolf DH. 1994. Proteinase yscD (oligopeptidase yscD), Structure, function and relationship of the yeast enzyme with mammalian thimet oligopeptidase (metalloendopeptidase, EP 24.15). Eur. J. Biochem. 219:627-39
207. Villanueva MS, Fischer P, Feen K, Pamer EG. 1994. Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1:479-89
208. Sijts AJ, Neisig A, Neefjes J, Pamer EG. 1996, Two Listeria monocytogenes CTL epitopes are processed from the same antigen with different efficiencies. J. Immunol. 156:683-92
209. Deng Y, Yewdell JW, Eisenlohr LC, Bennink JR. 1997. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J. Immunol. 158:1507-15
210. Chimini G, Pala P, Sire J, Jordan BR, Maryanski JL. 1989. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen. J. Exp. Med. 169:297-302
211. Hahn Y, Braciale V, Braciale T. 1991. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte. Recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product. J. Exp. Med. 174:733-36
212. Zaghouani H, Krystal M, Kuzu H, Moran T, Shah H, Kuzu Y, Schulman J, Bona C. 1992. Cells expressing an H chain Ig gene carrying a viral T cell epitope are lysed by specific cytolytic T cells. J. Immunol. 148:3604-9
213. Del Val M, Schlicht HJ, Ruppert T, Reddehase MJ, Koszinowski UH. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66:1145-53
214. Eisenlohr L Yewdell J, Bennink J. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-87
215. Shastri N, Serwold T, Gonzalez F. 1995. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. J. Immunol. 155:4339-46
216. Bergmann C, Yao Q, Ho C, Buckwold S. 1996. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 157:3242-49
217. Theobald M, Ruppert T, Kuckelkorn U, Haubler A, Biggs J, Levine A, Huber C, Koszinowski U, Kloetzel P-M, Sherman L. 1998. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphyocytes specific for a flanking peptide epitope. Submitted for publication
218. Shimbara N, Ogawa K, Hidaka Y, Nakajima H, Yamasaki N, Niwa S, Tanahashi N, Tanaka K. 1998. Contribution of proline residue for efficient production of MHC class I ligands by proteasomes [In Process Citation]. J. Biol. Chem. 273:23062 71
219. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-88
220. Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG. 1997. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94:12616-21
221. Rinat-Yehudar R, Groettrup M, Soza A, Kloetzel P, Ehrlich R. 1996. LMP-associated proteolytic activities and TAP-dependent peptide transport for class I molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. J. Exp. Med. 183:499-514